Can brain wiring predict opioid relapse? yale launches 240-Person study

NCT ID NCT06651333

Recruiting now Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study uses brain scans to understand why some people relapse to opioid use during treatment. Researchers at Yale will follow 240 adults recently started on methadone or buprenorphine, tracking their brain connectivity and drug use for six months. The goal is to identify patterns that predict relapse, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence opioid abuse Recurrence substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG USE DISORDER OPIOID ABUSE OPIOID DEPENDENCE OPIOID USE OPIOID-RELATED DISORDERS

Contacts and locations

Locations

Hartford Healthcare
RECRUITING

Hartford, Connecticut, 06102, United States
The APT Foundation
RECRUITING

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.